Triple reversal phenomenon in EGFR-mutant lung adenocarcinoma with prostate metastasis following hepatocellular carcinoma: a rare Case Report with diagnostic and therapeutic implications
BackgroundNon-small cell lung cancer harboring EGFR mutations is responsive to targeted therapies such as Osimertinib. Although metastasis from lung cancer to the prostate is exceedingly rare, we present a rare case of prostatic metastasis from lung adenocarcinoma in a patient with a history of hepa...
Saved in:
| Main Authors: | Jieyan Luo, Jie Zhou, Li Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1619466/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case Report: Peritoneal and small bowel metastasis from lung adenocarcinoma with EGFR L858R mutation
by: Tian Tan, et al.
Published: (2025-05-01) -
Optimal intervention timing for craniocerebral radiotherapy in EGFR mutant lung adenocarcinoma patients with brain metastases
by: Guangchuan Deng, et al.
Published: (2024-12-01) -
Profiling of driver mutations in lung adenocarcinoma patients identifies rare compound EGFR mutations sensitive to second-generation EGFR-TKIs
by: Jun Li, et al.
Published: (2024-12-01) -
EGFR-mutant lung adenocarcinoma transformed into small cell Lung cancer: A case report and literatures review
by: Jinhong Chen, et al.
Published: (2025-01-01) -
Real-world progression-free survival of first line afatinib patients with EGFR-mutant advanced lung adenocarcinoma: A multicentre study in Indonesia
by: Noni Novisari Soeroso, et al.
Published: (2025-01-01)